Company Data
Nektar Therapeutics
Ticker
NKTR
Current Price
$68.26 1.8%
Market Cap
$2.3B
Price Target
Refer to Report
Volume
538.3K
52wk Range
$21.02 - $109
Overview
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.